Waverly Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$531K Buy
12,451
+1,811
+17% +$80.9K ﹤0.01% 1150
2026
Q1
$513K Sell
10,640
-2,025
-16% -$94.4K ﹤0.01% 1075
2025
Q4
$614K Buy
12,665
+2,654
+27% +$132K 0.01% 925
2025
Q3
$473K Sell
10,011
-9
-0.1% -$434 ﹤0.01% 864
2025
Q2
$484K Buy
10,020
+174
+2% +$8.89K 0.01% 812
2025
Q1
$546K Buy
9,846
+56
+0.6% +$3.03K 0.01% 749
2024
Q4
$472K Buy
9,790
+4,082
+72% +$208K 0.01% 698
2024
Q3
$329K Hold
5,708
– – 0.01% 663
2024
Q2
$277K Buy
5,708
+906
+19% +$43.7K 0.01% 687
2024
Q1
$233K Buy
+4,802
New +$234K 0.01% 621
2015
Q4
– Sell
-83
Closed -$4K – 352
2015
Q3
$4K Hold
83
– – ﹤0.01% 391
2015
Q2
$4K Buy
+83
New +$4.21K ﹤0.01% 323
2014
Q4
– Sell
-331
Closed -$19K – 635
2014
Q3
$19K Hold
331
– – 0.01% 350
2014
Q2
$18K Hold
331
– – 0.01% 351
2014
Q1
$17K Sell
331
-449
-58% -$22.7K 0.01% 347
2013
Q4
$42K Buy
780
+331
+74% +$17.1K 0.01% 355
2013
Q3
$23K Buy
+449
New +$22.8K 0.01% 341

Other funds holding SNY

Waverly Advisors's SNY Position: Q2 2026 in Review

Waverly Advisors increased its Sanofi (SNY) stake by 17% in Q2 2026, buying an estimated $80.9K and bringing the position to 12,451 shares worth $531K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Waverly Advisors first reported a position in SNY in Q3 2013 and has held it in 17 quarters since. The position peaked at $614K in Q4 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Waverly Advisors held 12,451 shares of Sanofi worth $531K as of Q2 2026.
  • Waverly Advisors bought 1,811 Sanofi shares in Q2 2026, an estimated $80.9K.
  • Sanofi made up ﹤0.01% of Waverly Advisors's portfolio in Q2 2026, its #1150 holding.
  • Waverly Advisors first reported a position in Sanofi in Q3 2013 and has held it in 17 quarters since.
  • Waverly Advisors's Sanofi position peaked at $614K in Q4 2025.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.